Literature DB >> 12020974

Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders.

J C Huber1, C Schneeberger, C B Tempfer.   

Abstract

Estradiol is a pleiotropic hormone, involved in the etiology of a wide variety of diseases. Over the last decade individual genetic variability of the estradiol metabolism has been described as a significant contributor to disease susceptibility with variations depending on ethnic background. Among others, genetic variations of genes encoding cytochrome P450 (CYP) enzymes play an important role in this regard. Mutant alleles of the CYP 1A1 gene are major modulators of lung cancer risk among smokers, mediate gender differences in lung cancer susceptibility, and have been associated with an elevated risk for developing breast, prostate, colorectal, and oral squamous cell cancer. Variants of the CYP 1B1 gene modulate the risk for developing prostate, ovarian, lung, and breast cancer. Also, mutations in the CYP 1B1 gene are the major genetic determinant of congenital glaucoma. Mutant CYP 17 alleles are associated with serum and plasma levels of steroid hormones, use of hormone replacement therapy, and the development of endometrial, prostate, and breast cancer. Available data indicate that the protective effect against breast cancer of a later age at menarche is limited to wild-type CYP 17 allele carriers. Among women with the polycystic ovary syndrome, carriage of mutant CYP 17 alleles is sufficient to aggravate the clinical presentation of the disease. Molecular variants of the CYP 19 gene are associated with an increased risk for developing breast cancer, advanced breast cancer stages, and tumor aromatase production. Carriage of a mutant catechol-O-methyltransferase allele is associated with breast cancer, neurologic disorders such as Parkinson's disease, and modulates behavior among patients with schizophrenia, alcoholics and the general population. In summary, the available evidence points to genes that encode estrogen-metabolizing enzymes as strong hereditary determinants of the susceptibility to benign as well as malignant conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020974     DOI: 10.1016/s0378-5122(02)00021-x

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  10 in total

1.  Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma.

Authors:  Queeny K Y Chan; Ui-Soon Khoo; Kelvin Y K Chan; Hextan Y S Ngan; Shan-Shan Li; Pui-Man Chiu; Li-Shan Man; Philip P C Ip; Wei-Cheng Xue; Annie N Y Cheung
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

2.  Variation in the CYP19A1 gene and risk of colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Susan Kadlubar; Bette J Caan; John D Potter; Roger K Wolff
Journal:  Cancer Causes Control       Date:  2011-04-11       Impact factor: 2.506

3.  Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.

Authors:  Luigi Lorini; Michele Tomasoni; Cristina Gurizzan; Chiara Magri; Mattia Facchetti; Simonetta Battocchio; Chiara Romani; Marco Ravanelli; Arianna Oberti; Anna Bozzola; Elena Bardellini; Alberto Paderno; Davide Mattavelli; Davide Lombardi; Alberto Grammatica; Alberto Deganello; Fabio Facchetti; Stefano Calza; Alessandra Majorana; Cesare Piazza; Paolo Bossi
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

4.  Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome.

Authors:  Julia Pinsonneault; Wolfgang Sadée
Journal:  AAPS PharmSci       Date:  2003-11-05

5.  A Pooling Genome-Wide Association Study Combining a Pathway Analysis for Typical Sporadic Parkinson's Disease in the Han Population of Chinese Mainland.

Authors:  Yakun Hu; Libing Deng; Jie Zhang; Xin Fang; Puming Mei; Xuebing Cao; Jiari Lin; Yi Wei; Xiong Zhang; Renshi Xu
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

6.  Is oestrogen a 'biological neuroleptic'?

Authors:  Subhagata Chattopadyay
Journal:  Indian J Psychiatry       Date:  2003-10       Impact factor: 1.759

7.  Departure from multiplicative interaction for catechol-O-methyltransferase genotype and active/passive exposure to tobacco smoke among women with breast cancer.

Authors:  Brian D Bradbury; Jemma B Wilk; Ann Aschengrau; Timothy L Lash
Journal:  J Carcinog       Date:  2006-01-17

8.  Suppression of lymphoma growth by the xenoestrogens bisphenol A and genistein.

Authors:  Konstantin Yakimchuk; Chandrashekar Bangalore Revanna; Dan Huang; Jose Inzunza; Sam Okret
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

9.  Gender-related hormonal risk factors for oral cancer.

Authors:  Zsuzsanna Suba
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 2.874

10.  COMT polymorphism influences decrease of ovarian follicles and emerges as a predictive factor for premature ovarian insufficiency.

Authors:  Emerson Barchi Cordts; Monise Castro Santos; Carla Peluso; Erika Azuma Kayaki; Bianca Bianco; Caio Parente Barbosa; Denise Maria Christofolini
Journal:  J Ovarian Res       Date:  2014-05-02       Impact factor: 4.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.